Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10233322 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Investigation of Efficacy and Safety of EPOGAM
Conditions: Atopic Dermatitis;   Neurodermatitis
Intervention: Drug: EPOGAM 1000

Indicates status has not been verified in more than two years